[Evaluation of thomboembolic risk before ovarian stimulation: what balance? What prevention?].
The pathophysiology of thrombotic events remains unclear among women undergoing ovulation induction. In this review, present knowledge is summarized from the literature. Prospective studies are needed to determine risk factors and therapeutic approach of these thrombotic complications.
Verdy
E
E
Service d'hématologie biologique, Hôpital Tenon, 4, rue de Chine, 75020 Paris, France. elisabeth.verdy@tnn.ap-hop-paris.fr
D004967:Estrogens / Q000097:blood; D005260:Female; D006487:Hemostasis; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000097:blood; D010062:Ovulation Induction / Q000009:adverse effects*; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000209:etiology
D004967:Estrogens
Evaluation du risque thromboembolique avant stimulation ovarienne: quel bilan? Quelle prévention?